SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-21-006167
Filing Date
2021-05-27
Accepted
2021-05-27 17:10:22
Documents
12
Period of Report
2021-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_052321.htm   iXBRL 8-K 28023
  Complete submission text file 0001387131-21-006167.txt   199707

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE admp-20210523.xsd EX-101.SCH 2999
3 XBRL LABEL FILE admp-20210523_lab.xml EX-101.LAB 34238
4 XBRL PRESENTATION FILE admp-20210523_pre.xml EX-101.PRE 22341
5 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_052321_htm.xml XML 3589
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 21973995
SIC: 2834 Pharmaceutical Preparations